Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
2021
2020
Europe
Clear all
Type of publications
NITAG documentation
(93)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(2)
Topics
Available to download in languages
Regions
Europe
(96)
Africa
(20)
Americas
(129)
Eastern Mediterranean
(1)
South-East Asia
(4)
Western Pacific
(36)
Countries
Belgium
(18)
Denmark
(2)
France
(21)
Germany
(8)
Ireland
(7)
Netherlands
(7)
Spain
(1)
Sweden
(3)
United Kingdom
(27)
Diseases
COVID-19
(93)
Pneumococcal disease
(3)
Ebola
(3)
Hepatitis B
(1)
Human papillomavirus (HPV)
(6)
Influenza
(9)
Measles
(1)
Rotavirus
(1)
Tuberculosis
(2)
Typhoid
(1)
Varicella
(2)
Yellow fever
(1)
Vaccine topics
Acceptance
(1)
Coverage
(2)
Ethical issues
(1)
Target population
Adolescents
(1)
Adults
(2)
All age groups
(1)
Healthcare workers
(1)
Older adults
(2)
Pregnant women
(1)
Risk group
(2)
Publication date
2021
(77)
2020
(19)
2024
(2)
2023
(18)
2022
(37)
2019
(2)
2018
(4)
2017
(3)
2016
(3)
2015
(4)
2014
(2)
2013
(2)
2011
(2)
2010
(2)
2006
(1)
2005
(1)
96 results found
2021
∙
Health Council of the Netherlands
Executive summary of COVID-19 vaccination of children aged 5 to 11
2021
∙
Haute Autorité de Santé
HAS opinion relating to the launch of the 2021/2022 vaccination campaign against seasonal influenza in France in the northern hemisphere and in Mayotte in the context of the 'Covid-19 epidemic - May 12, 2021.
2021
∙
Haute Autorité de Santé
HAS recommendation on Place of Moderna's Spikevax® mRNA vaccine in 12 to 17 year olds - July 28, 2021
2021
∙
Haute Autorité de Santé
HAS recommendation on the place of a booster with the COMIRNATY mRNA vaccine
2021
∙
Haute Autorité de Santé
HAS recommendation on Vaccination strategy against Covid-19 - Place of the COMIRNATY® mRNA vaccine in 12-15 year olds - 3 June, 2021
2021
∙
Haute Autorité de Santé
HAS Sars-Cov-2 vaccination strategy - Role of socio-economic and professional factors in the risk of infection and severe forms of Covid-19 and updating of recommendations - 1 July 2021
2021
∙
Haut Conseil de la santé publique
HAS statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2021
∙
Haut Conseil de la santé publique
HAS statement relating to the possibility of carrying out a vaccination schedule with two mRNA vaccines of different specialties in exceptional situations - 29 April, 2021
2021
∙
Haute Autorité de Santé
HAS vaccination strategy against Covid-19 - Place of the COMIRNATY® mRNA vaccine in 12-15 year olds - 03 June, 2021
2021
∙
JCVI
JCVI advice on the UK vaccine response to the Omicron variant
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register